vs
ARBOR REALTY TRUST INC（ABR）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是ARBOR REALTY TRUST INC的1.5倍（$197.9M vs $133.4M），REPLIGEN CORP同比增速更快（13.6% vs -12.1%），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs -8.9%）
Arbor Realty Trust Inc.是总部位于美国的专业房地产投资信托（REIT）企业，主要为多户住宅及商业地产项目提供结构性融资服务，涵盖过渡贷款、机构贷款、夹层融资等品类，服务覆盖美国各地的地产持有者、开发商及房产投资群体。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
ABR vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.5倍
$133.4M
营收增速更快
RGEN
高出25.7%
-12.1%
两年增速更快
RGEN
近两年复合增速
-8.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $133.4M | $197.9M |
| 净利润 | — | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | — | 9.0% |
| 净利率 | — | 6.7% |
| 营收同比 | -12.1% | 13.6% |
| 净利润同比 | — | 143.9% |
| 每股收益（稀释后） | $0.08 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABRRGEN
| Q4 25 | $133.4M | $197.9M | ||
| Q3 25 | $112.4M | $188.8M | ||
| Q2 25 | $130.4M | $182.4M | ||
| Q1 25 | $134.2M | $169.2M | ||
| Q4 24 | $151.7M | $174.1M | ||
| Q3 24 | $156.7M | $154.9M | ||
| Q2 24 | $153.1M | $154.1M | ||
| Q1 24 | $160.7M | $151.3M |
净利润ABRRGEN
| Q4 25 | — | $13.3M | ||
| Q3 25 | $52.0M | $14.9M | ||
| Q2 25 | $36.3M | $14.9M | ||
| Q1 25 | $43.4M | $5.8M | ||
| Q4 24 | — | $-30.3M | ||
| Q3 24 | $73.5M | $-654.0K | ||
| Q2 24 | $61.8M | $3.3M | ||
| Q1 24 | $73.2M | $2.1M |
毛利率ABRRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率ABRRGEN
| Q4 25 | — | 9.0% | ||
| Q3 25 | — | 8.9% | ||
| Q2 25 | — | 7.6% | ||
| Q1 25 | — | 3.9% | ||
| Q4 24 | — | -17.7% | ||
| Q3 24 | — | -5.1% | ||
| Q2 24 | — | 1.0% | ||
| Q1 24 | 46.9% | 1.3% |
净利率ABRRGEN
| Q4 25 | — | 6.7% | ||
| Q3 25 | 46.3% | 7.9% | ||
| Q2 25 | 27.8% | 8.2% | ||
| Q1 25 | 32.3% | 3.4% | ||
| Q4 24 | — | -17.4% | ||
| Q3 24 | 46.9% | -0.4% | ||
| Q2 24 | 40.4% | 2.2% | ||
| Q1 24 | 45.6% | 1.4% |
每股收益（稀释后）ABRRGEN
| Q4 25 | $0.08 | $0.24 | ||
| Q3 25 | $0.20 | $0.26 | ||
| Q2 25 | $0.12 | $0.26 | ||
| Q1 25 | $0.16 | $0.10 | ||
| Q4 24 | $0.31 | $-0.55 | ||
| Q3 24 | $0.31 | $-0.01 | ||
| Q2 24 | $0.25 | $0.06 | ||
| Q1 24 | $0.31 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $482.9M | $767.6M |
| 总债务越低越好 | $11.1B | $542.2M |
| 股东权益账面价值 | $3.0B | $2.1B |
| 总资产 | $14.5B | $2.9B |
| 负债/权益比越低杠杆越低 | 3.75× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资ABRRGEN
| Q4 25 | $482.9M | $767.6M | ||
| Q3 25 | $423.4M | $748.7M | ||
| Q2 25 | $255.7M | $708.9M | ||
| Q1 25 | $308.8M | $697.2M | ||
| Q4 24 | $503.8M | $757.4M | ||
| Q3 24 | $687.5M | $784.0M | ||
| Q2 24 | $737.5M | $809.1M | ||
| Q1 24 | $908.0M | $780.6M |
总债务ABRRGEN
| Q4 25 | $11.1B | $542.2M | ||
| Q3 25 | $10.4B | $537.9M | ||
| Q2 25 | $10.1B | — | ||
| Q1 25 | $9.9B | — | ||
| Q4 24 | $10.0B | $525.6M | ||
| Q3 24 | $10.3B | — | ||
| Q2 24 | $10.6B | — | ||
| Q1 24 | $11.4B | — |
股东权益ABRRGEN
| Q4 25 | $3.0B | $2.1B | ||
| Q3 25 | $3.0B | $2.1B | ||
| Q2 25 | $3.0B | $2.1B | ||
| Q1 25 | $3.0B | $2.0B | ||
| Q4 24 | $3.0B | $2.0B | ||
| Q3 24 | $3.0B | $2.0B | ||
| Q2 24 | $3.1B | $2.0B | ||
| Q1 24 | $3.1B | $2.0B |
总资产ABRRGEN
| Q4 25 | $14.5B | $2.9B | ||
| Q3 25 | $13.9B | $2.9B | ||
| Q2 25 | $13.6B | $2.9B | ||
| Q1 25 | $13.4B | $2.9B | ||
| Q4 24 | $13.5B | $2.8B | ||
| Q3 24 | $13.9B | $2.8B | ||
| Q2 24 | $14.2B | $2.9B | ||
| Q1 24 | $15.1B | $2.8B |
负债/权益比ABRRGEN
| Q4 25 | 3.75× | 0.26× | ||
| Q3 25 | 3.47× | 0.26× | ||
| Q2 25 | 3.40× | — | ||
| Q1 25 | 3.29× | — | ||
| Q4 24 | 3.29× | 0.27× | ||
| Q3 24 | 3.40× | — | ||
| Q2 24 | 3.47× | — | ||
| Q1 24 | 3.68× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $372.4M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流ABRRGEN
| Q4 25 | $372.4M | $25.7M | ||
| Q3 25 | $178.7M | $48.1M | ||
| Q2 25 | $60.0M | $28.6M | ||
| Q1 25 | $150.5M | $15.0M | ||
| Q4 24 | $461.5M | $39.2M | ||
| Q3 24 | $85.0M | $49.3M | ||
| Q2 24 | $69.9M | $42.2M | ||
| Q1 24 | $260.0M | $44.7M |
自由现金流ABRRGEN
| Q4 25 | — | $17.6M | ||
| Q3 25 | — | $43.4M | ||
| Q2 25 | — | $21.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $33.6M | ||
| Q3 24 | — | $42.3M | ||
| Q2 24 | — | $37.4M | ||
| Q1 24 | — | $36.4M |
自由现金流率ABRRGEN
| Q4 25 | — | 8.9% | ||
| Q3 25 | — | 23.0% | ||
| Q2 25 | — | 11.8% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | — | 19.3% | ||
| Q3 24 | — | 27.3% | ||
| Q2 24 | — | 24.3% | ||
| Q1 24 | — | 24.0% |
资本支出强度ABRRGEN
| Q4 25 | — | 4.1% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 3.9% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 5.5% |
现金转化率ABRRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | 3.44× | 3.23× | ||
| Q2 25 | 1.65× | 1.92× | ||
| Q1 25 | 3.47× | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.16× | — | ||
| Q2 24 | 1.13× | 12.70× | ||
| Q1 24 | 3.55× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
